Clinical Trials Logo

Postoperative Analgesia clinical trials

View clinical trials related to Postoperative Analgesia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06260137 Active, not recruiting - Clinical trials for Postoperative Analgesia

Comparison of Two Different Methods for Reducing Pain After Lung Surgery

Start date: July 10, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical study is to compare the effectiveness of the Rhomboid Intercostal Block and Sub-Servitus plan block and the effectiveness of the Rhomboid intercostal block in patients with video-supported thoracoscopic surgery. The main question it aims to answer is: Which of these two blocks more effectively reduces the patients' pain?

NCT ID: NCT05718544 Active, not recruiting - Dexmedetomidine Clinical Trials

Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

Start date: January 30, 2023
Phase: Phase 4
Study type: Interventional

Chronic postsurgical pain (CPSP) refers to pain that occurs or increases after surgery and lasts longer than 3 months. Severe postoperative acute pain is one of the major risk factors of CPSP. Spine surgery brings severe postoperative pain due to large trauma and long duration. Ketamine and esketamine are N-methyl-D-aspartate receptor antagonists; they have anti-hyperalgesic effects and may reduce CPSP. Dexmedetomidine is an alpha 2-adrenoceptor agonist with sedative, anxiolytic, and analgesic effect; it is frequently used as an adjuvant to postoperative analgesia. In a previous trial of the investigators, 200 patients following scoliosis correction surgery were randomzied to receive opioid analgsia supplemented with either mini-dose esketamine-dexmedetomidine combination or placebo. The results showed that esketamine-dexmedetomidine supplement analgesia significantly improved analgesia and sleep quality after surgery. This study is designed to test the hypothesis that mini-dose esketamine-dexmedetomidine supplemented analgesia may reduce CPSP at 2 years after scoliosis correction surgery.

NCT ID: NCT03673280 Active, not recruiting - Clinical trials for Postoperative Analgesia

Quadratus Lumborum in Cesarean Section Trial

QUALICS
Start date: March 18, 2018
Phase: N/A
Study type: Interventional

Postoperative pain of a caesarean section may be of high intensity, especially in the first 48 hours after the procedure, which affects the mother / newborn relationship, in addition to having the potential to progress to chronic pain. The use of intrathecal morphine is effective in post-caesarean analgesia, but carries unwanted side effects, including nausea, vomiting, urinary retention and pruritus. Therefore, alternative techniques of analgesia become necessary. First described in 2007, ultrasound-guided quadratus lumborum (QL) block has gained prominence due to its analgesic superiority to the TAP block. Besides providing somatic analgesia, it also seems to inhibit visceral pain because the local anesthetic reaches the paravertebral space, this was observed by magnetic resonance imaging with contrast medium injected at the QL block site.